Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic R Curtiss

Showing results (91-100 of 138) with videos related to

Pageof 14
Sort By:
Journal of Managed Care Pharmacy : JMCP|April 29, 2008
HEDIS, beta-blockers, and what more can be done to improve secondary prevention in ACSFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|December 11, 2003
The relative value of disease management programs versus drug manufacturer rebatesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 23, 2005
Selectivity and specificity are the keys to cost-effective use of omalizumab for allergic asthmaFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|April 21, 2006
Relative value of the NSAIDs, including COX-2 inhibitors and meloxicamFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|July 2, 2004
Methods to attain optimal outcomes with lipid-lowering drug therapyFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|December 11, 2003
Consensus panel, national guidelines, and other potentially misleading termsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 16, 2005
Evidence-based medicine: United States, the last venue for direct-to-consumer advertising, props up the erectile dysfunction marketFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
What evidence supports guidelines for use of ACE inhibitors and ARBs in diabetes?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 31, 2009
Omalizumab and other new drug therapies occupy a small space in asthma disease managementFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|July 4, 2007
Effective integration of medical and pharmacy claims to better protect patient safety--a long road yet to travelFrederic R Curtiss
Pageof 14

Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Journal of Managed Care Pharmacy : JMCP|April 29, 2008
HEDIS, beta-blockers, and what more can be done to improve secondary prevention in ACSFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|December 11, 2003
The relative value of disease management programs versus drug manufacturer rebatesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|November 23, 2005
Selectivity and specificity are the keys to cost-effective use of omalizumab for allergic asthmaFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|April 21, 2006
Relative value of the NSAIDs, including COX-2 inhibitors and meloxicamFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|July 2, 2004
Methods to attain optimal outcomes with lipid-lowering drug therapyFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|December 11, 2003
Consensus panel, national guidelines, and other potentially misleading termsFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 16, 2005
Evidence-based medicine: United States, the last venue for direct-to-consumer advertising, props up the erectile dysfunction marketFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|February 3, 2007
What evidence supports guidelines for use of ACE inhibitors and ARBs in diabetes?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 31, 2009
Omalizumab and other new drug therapies occupy a small space in asthma disease managementFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|July 4, 2007
Effective integration of medical and pharmacy claims to better protect patient safety--a long road yet to travelFrederic R Curtiss
Pageof 14